Literature DB >> 12746564

Decreased expression of calcium receptor in parathyroid tissue in patients with hyperparathyroidism secondary to chronic renal failure.

María Martín-Salvago1, José L Villar-Rodríguez, Alfonso Palma-Alvarez, Antonio Beato-Moreno, Hugo Galera-Davidson.   

Abstract

The response of parathyroid cells to serum calcium is regulated by a calcium-sensing receptor protein (CaR). In patients with chronic renal failure, hypocalcemia contributes to the parathyroid hyperplasia and increased parathyroid hormone secretion characteristic of secondary hyperparathyroidism (sHPT). However, patients with uremia also display reduced sensitivity to extracellular calcium; this seems to be owing to an alteration of the receptor mechanism. This study examined calcium receptor expression in the parathyroid tissue of patients with sHPT, using immunohistochemical techniques and comparison with normal tissue and parathyroid glands of patients with primary hyperparathyroidism. In all the glands studied, immunostaining was more intense in chief cells than in oxyphilic, transitional, and clear cells. The parathyroid glands of patients with sHPT displayed significantly reduced expression of CaR with respect to morphologically normal ones; a very similar reduction is reported in adenomas. Furthermore, in glands displaying multinodular hyperplasia, expression was less marked in nodule-forming cells than in internodular areas. The decreased expression of calcium receptors in the parathyroid tissue of uremic patients was thought to be owing to the different cell populations present; these parathyroid glands contained predominantly transitional, oxyphilic, and clear cells, which normally express fewer receptors than chief cells, which are more abundant in normal glands.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12746564     DOI: 10.1385/ep:14:1:61

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  23 in total

1.  Analysis of proliferative activity of the parathyroid glands using proliferating cell nuclear antigen in patients with hyperparathyroidism.

Authors:  S Yamaguchi; S Yachiku; M Morikawa
Journal:  J Clin Endocrinol Metab       Date:  1997-08       Impact factor: 5.958

2.  Secretory dysfunction in parathyroid cells from a neonate with severe primary hyperparathyroidism.

Authors:  S J Marx; R D Lasker; E M Brown; L A Fitzpatrick; N B Sweezey; R B Goldbloom; D A Gillis; D E Cole
Journal:  J Clin Endocrinol Metab       Date:  1986-02       Impact factor: 5.958

3.  Direct comparison in vivo and in vitro of suppressibility of parathyroid function by calcium in primary hyperparathyroidism.

Authors:  E M Brown; A E Broadus; M F Brennan; D G Gardner; S J Marx; A M Spiegel; R W Downs; M Attie; G D Aurbach
Journal:  J Clin Endocrinol Metab       Date:  1979-04       Impact factor: 5.958

4.  Direct regulation by calcium of cytoplasmic messenger ribonucleic acid coding for pre-proparathyroid hormone in isolated bovine parathyroid cells.

Authors:  J Russell; D Lettieri; L M Sherwood
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

5.  Calcium infusion suggests a "set-point" abnormality of parathyroid gland function in familial benign hypercalcemia and more complex disturbances in primary hyperparathyroidism.

Authors:  S Khosla; P R Ebeling; A F Firek; M M Burritt; P C Kao; H Heath
Journal:  J Clin Endocrinol Metab       Date:  1993-03       Impact factor: 5.958

6.  Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism.

Authors:  M R Pollak; E M Brown; Y H Chou; S C Hebert; S J Marx; B Steinmann; T Levi; C E Seidman; J G Seidman
Journal:  Cell       Date:  1993-12-31       Impact factor: 41.582

7.  Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism.

Authors:  O Kifor; F D Moore; P Wang; M Goldstein; P Vassilev; I Kifor; S C Hebert; E M Brown
Journal:  J Clin Endocrinol Metab       Date:  1996-04       Impact factor: 5.958

Review 8.  New aspects in the control of parathyroid hormone secretion.

Authors:  J Silver; E Moallem; E Epstein; R Kilav; T Naveh-Many
Journal:  Curr Opin Nephrol Hypertens       Date:  1994-07       Impact factor: 2.894

9.  Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D.

Authors:  T Naveh-Many; R Rahamimov; N Livni; J Silver
Journal:  J Clin Invest       Date:  1995-10       Impact factor: 14.808

10.  The modulation of circulating parathyroid hormone immunoheterogeneity in man by ionized calcium concentration.

Authors:  P D'Amour; J Palardy; G Bahsali; L E Mallette; A DeLéan; R Lepage
Journal:  J Clin Endocrinol Metab       Date:  1992-03       Impact factor: 5.958

View more
  7 in total

Review 1.  Bone Disease in CKD in Children.

Authors:  Fernando Santos; Lucas Díaz-Anadón; Flor A Ordóñez; Dieter Haffner
Journal:  Calcif Tissue Int       Date:  2021-01-16       Impact factor: 4.333

Review 2.  The regulation of parathyroid hormone secretion and synthesis.

Authors:  Rajiv Kumar; James R Thompson
Journal:  J Am Soc Nephrol       Date:  2010-12-16       Impact factor: 10.121

Review 3.  Calcium sensing by endocrine cells.

Authors:  Edward M Brown
Journal:  Endocr Pathol       Date:  2004       Impact factor: 3.943

Review 4.  Intratumor heterogeneity in human parathyroid tumors.

Authors:  C Verdelli; G S Tavanti; S Corbetta
Journal:  Histol Histopathol       Date:  2020-05-29       Impact factor: 2.303

5.  Dynamics of parathyroid hormone secretion after total parathyroidectomy and autotransplantation.

Authors:  Luiz Carlos Conti-Freitas; Maria Cristina Foss-Freitas; Leandro Junior Lucca; Jose Abrão Cardeal da Costa; Rui Celso Martins Mamede; Milton Cesar Foss
Journal:  World J Surg       Date:  2009-07       Impact factor: 3.352

Review 6.  Calcium-sensing receptor in cancer: good cop or bad cop?

Authors:  Bandana Chakravarti; Shailendra Kumar Dhar Dwivedi; Ambrish Mithal; Naibedya Chattopadhyay
Journal:  Endocrine       Date:  2008-11-15       Impact factor: 3.633

Review 7.  Chronic kidney disease: mineral and bone disorder in children.

Authors:  Katherine Wesseling-Perry; Isidro B Salusky
Journal:  Semin Nephrol       Date:  2013-03       Impact factor: 5.299

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.